Pierre Regis Burgel
Overview
Explore the profile of Pierre Regis Burgel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spinou A, Hererro-Cortina B, Aliberti S, Goeminne P, Polverino E, Dimakou K, et al.
Eur Respir J
. 2024 Apr;
63(6).
PMID: 38609097
Background: International guidelines recommend airway clearance management as one of the important pillars of bronchiectasis treatment. However, the extent to which airway clearance is used for people with bronchiectasis in...
2.
Mabo A, Borie R, Wemeau-Stervinou L, Uzunhan Y, Gomez E, Prevot G, et al.
Thorax
. 2023 Sep;
79(1):68-74.
PMID: 37758458
Background: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease, predisposing to an increased risk of infection. A complete picture of these infections is lacking. Research Question: Describe the characteristics...
3.
Dreano E, Burgel P, Hatton A, Bouazza N, Chevalier B, Macey J, et al.
Eur Respir J
. 2023 Sep;
62(4).
PMID: 37696564
Background: Around 20% of people with cystic fibrosis (pwCF) do not have access to the triple combination elexacaftor/tezacaftor/ivacaftor (ETI) in Europe because they do not carry the F508del allele on...
4.
Chalmers J, Polverino E, Crichton M, Ringshausen F, Soyza A, Vendrell M, et al.
Lancet Respir Med
. 2023 Apr;
11(7):637-649.
PMID: 37105206
Background: Bronchiectasis is a heterogeneous, neglected disease with few multicentre studies exploring the causes, severity, microbiology, and treatment of the disease across Europe. This aim of this study was to...
5.
Le Pavec J, Pison C, Hirschi S, Bunel V, Mordant P, Brugiere O, et al.
Respir Med Res
. 2022 Dec;
83:100981.
PMID: 36565563
Lung transplantation (LTx) is a steadily expanding field. The considerable developments have been driven over the years by indefatigable work conducted at LTx centers to improve donor and recipient selection,...
6.
Coriati A, Ma X, Sykes J, Stanojevic S, Ruseckaite R, Lemonnier L, et al.
Thorax
. 2022 Sep;
78(3):242-248.
PMID: 36109163
Background: Life expectancy for people with cystic fibrosis (CF) varies considerably both within and between countries. The objective of this study was to compare survival among countries with single-payer healthcare...
7.
Reix P, Tatopoulos A, Ioan I, Le Bourgeois M, Bui S, Choukroun M, et al.
J Cyst Fibros
. 2021 Jun;
21(1):155-159.
PMID: 34183285
Lung clearance index (LCI) is a biomarker of ventilation inhomogeneity. Data are scarce on its usefulness in daily practice for monitoring the effects of treatments in older children and adults...
8.
Reynaud Q, Bricca R, Cavalli Z, Nove-Josserand R, Durupt S, Reix P, et al.
Pediatr Pulmonol
. 2020 Jul;
55(10):2653-2661.
PMID: 32603551
Background: To better understand the mechanisms of infection with nontuberculous mycobacteria (NTM) in patients with cystic fibrosis (CF), we explore different risk factors associated with NTM positivity in a meta-analysis....
9.
Perez T, Deslee G, Burgel P, Caillaud D, Le Rouzic O, Zysman M, et al.
Int J Chron Obstruct Pulmon Dis
. 2019 Jul;
14:1399-1410.
PMID: 31308646
The 6-min walk test (6MWT) allows exercise tolerance to be assessed, and it has a significant prognostic value in COPD. The goal of this study was to analyse the determinants...
10.
Ladjemi M, Burgel P, Pilette C
Am J Respir Crit Care Med
. 2019 Jan;
199(9):1171-1172.
PMID: 30633554
No abstract available.